These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34070345)

  • 1. A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms.
    Masini D; Plewnia C; Bertho M; Scalbert N; Caggiano V; Fisone G
    Biomedicines; 2021 May; 9(6):. PubMed ID: 34070345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
    Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
    Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.
    Bonito-Oliva A; Masini D; Fisone G
    Front Behav Neurosci; 2014; 8():290. PubMed ID: 25221486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson's Disease.
    Xie C; Prasad AA
    Microorganisms; 2020 Oct; 8(11):. PubMed ID: 33120961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Kumari R; Kumar JB; Luthra PM
    Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of the rat medial forebrain lesion model to study prefrontal cortex mediated cognitive tasks in Parkinson's disease.
    Marshall CA; King KM; Kortagere S
    Brain Res; 2019 Jan; 1702():105-113. PubMed ID: 29608880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.
    Rampersaud N; Harkavyi A; Giordano G; Lever R; Whitton J; Whitton PS
    Neuropeptides; 2012 Oct; 46(5):183-93. PubMed ID: 22921965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers.
    Requejo C; López-de-Ipiña K; Ruiz-Ortega JÁ; Fernández E; Calvo PM; Morera-Herreras T; Miguelez C; Cardona-Grifoll L; Cepeda H; Ugedo L; Lafuente JV
    Front Neurosci; 2020; 14():590029. PubMed ID: 33154717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric and Cognitive Deficits in Parkinson's Disease and Their Modeling in Rodents.
    Decourt M; Jiménez-Urbieta H; Benoit-Marand M; Fernagut PO
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34204380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
    Vieira JCF; Bassani TB; Santiago RM; de O Guaita G; Zanoveli JM; da Cunha C; Vital MABF
    Behav Brain Res; 2019 Oct; 371():111981. PubMed ID: 31141725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease.
    Chiu WH; Depboylu C; Hermanns G; Maurer L; Windolph A; Oertel WH; Ries V; Höglinger GU
    Neuropharmacology; 2015 Aug; 95():367-76. PubMed ID: 25839898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's Disease.
    Kostrzewa JP; Kostrzewa RA; Kostrzewa RM; Brus R; Nowak P
    Curr Top Behav Neurosci; 2016; 29():313-332. PubMed ID: 26475156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson's disease.
    Quiroga-Varela A; Aguilar E; Iglesias E; Obeso JA; Marin C
    Neuroscience; 2017 Oct; 361():144-156. PubMed ID: 28823819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal Model for Prodromal Parkinson's Disease.
    Taguchi T; Ikuno M; Yamakado H; Takahashi R
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
    Goes AT; Souza LC; Filho CB; Del Fabbro L; De Gomes MG; Boeira SP; Jesse CR
    Neuroscience; 2014 Jan; 256():61-71. PubMed ID: 24090962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
    Marques NF; Binder LB; Roversi K; Sampaio TB; Constantino LC; Prediger RD; Tasca CI
    Behav Brain Res; 2019 Oct; 372():112014. PubMed ID: 31212060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.